Merve Mutlu
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Retinal Development and Disorders
- Circular RNAs in diseases
- RNA modifications and cancer
- CRISPR and Genetic Engineering
- RNA Research and Splicing
- DNA Repair Mechanisms
Papers in
-
- MicroRNA in disease regulation 3
- Cancer Genomics and Diagnostics 1
-
- Protein Degradation and Inhibitors 3
- RNA modifications and cancer 2
- DNA Repair Mechanisms 2
- Ubiquitin and proteasome pathways 2
- Co-authors
- Özge Saatci (3 shared papers)Ozgur D. Sahin (3 shared papers)Umar Raza (3 shared papers)Erol Eyüpoğlu (2 shared papers)Suhail A. Ansari (2 shared papers)Özlen Konu (1 shared paper)Riccardo Sangermano (1 shared paper)Gülnur Güler (1 shared paper)
- Journals
- Cell Reports (2 papers)Oncotarget (1 paper)Cell (1 paper)Molecular Oncology (1 paper)Journal of Molecular Medicine (1 paper)
- Partner nations
- SwitzerlandTürkiyeNetherlands
In The Last Decade
Merve Mutlu
13 papers receiving 401 citations
Peers
Comparison fields: 5 of 70
- Cancer Research 133
- Molecular Biology 263
- Ophthalmology 18
- Oncology 53
- Immunology 30
Countries citing papers authored by Merve Mutlu
This map shows the geographic impact of Merve Mutlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merve Mutlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merve Mutlu more than expected).
Fields of papers citing papers by Merve Mutlu
This network shows the impact of papers produced by Merve Mutlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merve Mutlu. The network helps show where Merve Mutlu may publish in the future.
Co-authors
The 25 scholars most cited alongside Merve Mutlu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 119 | |
| 2 | 2014 | 68 | |
| 3 | 2016 | 57 | |
| 4 | 2016 | 46 | |
| 5 | 2020 | 35 | |
| 6 | 2024 | 23 | |
| 7 | 2024 | 17 | |
| 8 | 2016 | 15 | |
| 9 | 2018 | 12 | |
| 10 | 2022 | 6 | |
| 11 | 2020 | 4 | |
| 12 | 2023 | 2 | |
| 13 | 2019 | 1 |
About Merve Mutlu
Merve Mutlu is a scholar working on Cancer Research, Molecular Biology, Oncology, Otorhinolaryngology and Ophthalmology, having authored 13 papers that have together received 405 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (3 papers), MicroRNA in disease regulation (3 papers), RNA modifications and cancer (2 papers), DNA Repair Mechanisms (2 papers), PARP inhibition in cancer therapy (2 papers), Ubiquitin and proteasome pathways (2 papers), Cancer Genomics and Diagnostics (1 paper) and interferon and immune responses (1 paper). The work is most often cited by research in Cancer Research (133 citations), Molecular Biology (263 citations), Ophthalmology (18 citations), Oncology (53 citations) and Immunology (30 citations). Merve Mutlu has collaborated with scholars based in Switzerland, Türkiye and Netherlands. Frequent co-authors include Özge Saatci, Ozgur D. Sahin, Umar Raza, Erol Eyüpoğlu, Suhail A. Ansari, Özlen Konu, Riccardo Sangermano, Gülnur Güler, Hayriye Tatlı Doğan and Erdoğan Doğdu. Their work appears in journals such as Cell Reports, Oncotarget, Cell, Molecular Oncology and Journal of Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.